Status:
COMPLETED
14729-D9831C00002- 1 Month Biopsy Study
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to study histological changes, cellularity, clinical efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease
Eligibility Criteria
Inclusion
- Men or women 40 years or above
- FEV1 between 40 and 80% of predicted normal value post-bronchodilator
- Clinical diagnosis of COPD
Exclusion
- Other clinically relevant disease or disorders
- Exacerbation of COPD within 30 days
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00766415
Start Date
November 1 2008
End Date
June 1 2009
Last Update
February 28 2014
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Frieburg, Germany
2
Research Site
Großhansdorf, Germany
3
Research Site
Hanover, Germany
4
Research Site
Amsterdam, Netherlands